首页> CNS spectrums> Effects of esketamine nasal spray on depressive symptom severity in adults with treatment-resistant depression and associations between the Montgomery-Åsberg Depression Rating Scale and the 9-item Patient Health Questionnaire.

Effects of esketamine nasal spray on depressive symptom severity in adults with treatment-resistant depression and associations between the Montgomery-Åsberg Depression Rating Scale and the 9-item Patient Health Questionnaire.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jennifer,Kern Sliwa

第一单位： CNS Medical Information, Janssen Scientific Affairs, LLC, Titusville, NJ, USA.

作者： Jennifer,Kern Sliwa ^[1] ; Ronaldo R,Naranjo ^[2] ; Ibrahim,Turkoz ^[3] ; Mary Pat,Petrillo ^[4] ; Patricia,Cabrera ^[5] ; Madhukar,Trivedi ^[6]

作者单位： CNS Medical Information, Janssen Scientific Affairs, LLC, Titusville, NJ, USA. ^[1] US Neuroscience Medical Affairs, Janssen Scientific Affairs, LLC, Titusville, NJ, USA. ^[2] Statistics & Decision Sciences, Janssen Research & Development, LLC, a Johnson & Johnson company, Titusville, NJ, USA. ^[3] Value & Evidence Scientific Engagement, Janssen Scientific Affairs, LLC, Titusville, NJ, USA. ^[4] Neuroscience, Janssen Scientific Affairs, LLC, Titusville, NJ, USA. ^[5] Center for Depression Research and Clinical Care, Peter O'Donnell Jr. Brain Institute and Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA. ^[6]

关键词 Depression esketamine nasal spray oral antidepressant severity treatment resistant